Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antigen excess detection by automated assays for free light chains.
Bossuyt X, Delforge M, Reynders M, Dillaerts D, Sprangers B, Fostier K, Poesen K, Vercammen M. Bossuyt X, et al. Among authors: fostier k. Clin Chem Lab Med. 2018 Aug 28;56(9):e235-e238. doi: 10.1515/cclm-2017-0977. Clin Chem Lab Med. 2018. PMID: 29679525 No abstract available.
Serum free light chain analysis: persisting limitations with new kids on the block.
Van Hoovels L, Vercammen M, Nevejan L, Cornette M, Briers PJ, Deeren D, Van Droogenbroeck J, Fostier K, De Smet D. Van Hoovels L, et al. Among authors: fostier k. Clin Chem Lab Med. 2022 Jul 4;60(9):1440-1448. doi: 10.1515/cclm-2022-0347. Print 2022 Aug 26. Clin Chem Lab Med. 2022. PMID: 35781357
COVID-19, impact on myeloma patients.
Dufour I, Raedemaeker J, Andreozzi F, Verstraete G, Bailly S, Delforge M, Storms P, Jacquy C, Van de Velde A, Mineur P, Lejeune M, Bauwens D, Van Obbergh F, Kentos A, Nguyen J, Fostier K, De Weweire A, Meuleman N, Vekemans MC. Dufour I, et al. Among authors: fostier k. Ann Hematol. 2020 Aug;99(8):1947-1949. doi: 10.1007/s00277-020-04147-7. Epub 2020 Jun 23. Ann Hematol. 2020. PMID: 32577846 Free PMC article. No abstract available.
Validation of a PCR-Based Next-Generation Sequencing Approach for the Detection and Quantification of Minimal Residual Disease in Acute Lymphoblastic Leukemia and Multiple Myeloma Using gBlocks as Calibrators.
Van der Straeten J, De Brouwer W, Kabongo E, Dresse MF, Fostier K, Schots R, Van Riet I, Bakkus M. Van der Straeten J, et al. Among authors: fostier k. J Mol Diagn. 2021 May;23(5):599-611. doi: 10.1016/j.jmoldx.2021.01.009. Epub 2021 Feb 4. J Mol Diagn. 2021. PMID: 33549860 Free article.
Cellular immunotherapy in multiple myeloma: lessons from preclinical models.
Binsfeld M, Fostier K, Muller J, Baron F, Schots R, Beguin Y, Heusschen R, Caers J. Binsfeld M, et al. Among authors: fostier k. Biochim Biophys Acta. 2014 Dec;1846(2):392-404. doi: 10.1016/j.bbcan.2014.08.001. Epub 2014 Aug 7. Biochim Biophys Acta. 2014. PMID: 25109893 Free article. Review.
Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model.
Nur H, Fostier K, Aspeslagh S, Renmans W, Bertrand E, Leleu X, Favreau M, Breckpot K, Schots R, De Waele M, Van Valckenborgh E, De Bruyne E, Facon T, Elewaut D, Vanderkerken K, Menu E. Nur H, et al. Among authors: fostier k. PLoS One. 2013 May 31;8(5):e65075. doi: 10.1371/journal.pone.0065075. Print 2013. PLoS One. 2013. PMID: 23741460 Free PMC article.
The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy.
Puttemans J, Stijlemans B, Keyaerts M, Vander Meeren S, Renmans W, Fostier K, Debie P, Hanssens H, Rodak M, Pruszynski M, De Veirman K, Vanderkerken K, Lahoutte T, Morgenstern A, Bruchertseifer F, Devoogdt N, D'Huyvetter M. Puttemans J, et al. Among authors: fostier k. Mol Cancer Ther. 2022 Jan;21(1):159-169. doi: 10.1158/1535-7163.MCT-21-0220. Epub 2021 Oct 19. Mol Cancer Ther. 2022. PMID: 34667109 Free PMC article.
27 results